Optimizing Ampicillin Dosing for Preterm Infants
Part of Infections clinical trials.
This study aims to find the best dose of ampicillin for premature babies in the NICU who are being treated for possible early infection. The goal is to improve treatment and reduce side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is a premature infant born at 34 weeks of pregnancy or less.
- Your baby is less than 7 days old when checked for the study.
- Your baby is in the Duke NICU and has been prescribed ampicillin for possible early infection.
- You must give permission (informed consent) for your baby to join.
- Your baby does not have a confirmed infection or a major birth defect that would affect survival.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at spacing out doses of the antibiotic gentamicin for newborns up to 7 days old who need it. The goal is to make sure the dosing schedule works well and is safe for babies.
This trial compares giving a long, continuous infusion versus standard short infusions of certain antibiotics (beta-lactams) to children with sepsis in intensive care. The goal is to find which method works better and is safer.
This trial is testing ways to make the best treatment decisions for newborns who may have an early infection (sepsis). It focuses on babies born at 34 weeks or later and within their first three days of life.
This trial compares two approaches for premature babies born at 26 to 34 weeks who have risk factors for early infection: giving antibiotics only if they develop signs of infection versus giving them right away. It aims to find out if waiting is safe and reduces unnecessary antibiotic use.
This study aims to find the best dose of the antibiotic colistin for premature babies (born before 37 weeks) in the neonatal intensive care unit who have a serious infection that is resistant to other antibiotics. The goal is to treat the infection effectively while reducing the risk of kidney damage.
This study checks if a blood test (presepsin) can help doctors safely stop antibiotics earlier in preterm babies at moderate risk of infection. The goal is to reduce unnecessary antibiotic use.
Hear when a new Early Onset Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.